A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy

Journal of Clinical Investigation

Volumn 104, Issue 6, 1999, Pages 815-823

  Braun Dullaeus, Ruediger C ^a,b   Mann, Michael J ^b   Ziegler, Almut ^a   Von Der Leyen, Heiko E ^c   Dzau, Victor J ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANTISENSE OLIGODEOXYNUCLEOTIDE; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; GREEN FLUORESCENT PROTEIN; PROTEIN P27;

ANIMAL CELL; ARTICLE; CELL CYCLE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME INHIBITION; GENE OVEREXPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE;

EID: 0032719663     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI5339     Document Type: Article

References (40)

1. Geisterfer, A.A., Peach, M.J., and Owens, G.K. 1988. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aotric smooth muscle cells. Circ. Res. 62:749-756.
2. Gibbons, G.H., Pratt, R.E., and Dzau, V.J. 1992. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J. Clin. Invest. 90:456-461.
3. Berk, B.C., Vekshtein, V., Gordon, H.M., and Tsuda, T. 1989. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension. 13:305-314.
4. Naftilan, A.J., Pratt, R.E., and Dzau, V.J. 1989. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J. Clin. Invest. 83:1419-1424.
5. Naftilan, A.J., Gilliland, G.K., Eldridge, C.S., and Kraft, A.S. 1990. Induction of the proto-oncogene c-jun by angiotensin II. Mol. Cell. Biol. 10:5536-5540.
6. Braun-Dullaeus, R.C., Mann, M.J., and Dzau, V.J. 1998. Cell cycle progression. New therapeutic target for vascular proliferative disease. Circulation. 98:82-89.
7. Chellappan, S.P., Giordano, A., and Fisher, P.B. 1998. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development. Curr. Top. Microbiol. Immunol. 227:57-103.
8. Sherr, C.J. 1995. Mammalian G1 cyclins and cell cycle progression. Proc. Assoc. Am. Physicians. 107:181-186.
9. King, R.W., Jackson, P.K., and Kirschner, M.W. 1994. Mitosis in transition. Cell. 79:563-571.
10. Stillman, B. 1994. Smart machines at the DNA replication fork. Cell. 78:725-728.
11. Sherr, C.J., and Roberts, J.M. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
12. Owens, G.K., Loeb, A., Gordon, D., and Thompson, M.M. 1986. Expression of smooth muscle-specific alpha-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation. J. Cell Biol. 102:343-352.
13. Coats, S., Flanagan, W.M., Nourse, J., and Roberts, J.M. 1996. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science. 272:877-880.
14. Lewis, J.G., et al. 1996. A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Proc. Natl. Acad. Sci. USA. 93:3176-3181.
15. Wang, X., Gorospe, M., Huang, Y., and Holbrook, N.J. 1997. p27Kip1 overexpression causes apoptotic death of mammalian cells. Oncogene. 15:2991-2997.
16. Katayose, Y., et al. 1997. Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27Kip1. Cancer Res. 57:5441-54-45.
17. Pratt, R.E., and Dzau, V.J. 1996. Pharmacological strategies to prevent restenosis. Lessons learned from blockade of the renin-angiotensin system. Circulation. 93:848-852.
18. Campbell-Boswell, M., and Robertson, A.L., Jr. 1981. Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp. Mol. Pathol. 35:265-276.
19. Brooks, R.F. 1977. Continuous protein synthesis is required to maintain the probability of entry into S phase. Cell. 12:311-317.
20. Rhoads, R.E. 1991. Protein synthesis, cell growth, and oncogenesis. Curr. Opin. Cell Biol. 5:1019-1024.
21. Grammer, T.C., Cheatham, L., Chou, M.M., and Blenis, J. 1996. The p70S6K signalling pathway: a novel signalling system involved in growth regulation. Cancer Surv. 27:271-292.
22. Sonenberg, N. 1994. Regulation of translation and cell growth by eIF-4E. Biochimie. 76:839-846.
23. Sadoshima, J., and Izumo, S. 1995. Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kd S6 kinase in angiotensin II-induced cardiac hypertrophy. Circ. Res. 77:1040-1052.
24. Braun-Dullaeus, R.C., Mann, M.J., von der Leyen, H.E., Morris, R.E., and Dzau, V.J. 1997. Cell cycle protein expression in proliferating vascular smooth muscle cells is translationally regulated through mTOR and p70S6 kinase. Circulation. 96:1-47. (Abstr.)
25. Leicht, M., Simm, A., Bertsch, G., and Hoppe, J. 1996. Okadaic acid induces cellular hypertrophy in AKR-2B fibroblasts: involvement of the p70S6 kinase in the onset of protein and rRNA synthesis. Cell Growth Differ. 7:1199-1209.
26. Watanabe, G., et al. 1996. Angiotensin II activation ofcyclin D1-dependent kinase activity. J. Biol. Chem. 271:22570-22577.
27. Sadoshima, J., Aoki, H., and Izumo, S. 1997. Angiotensin II and serum differentially regulate expression of cyclins, activity of cyclin-dependent kinases, and phosphorylation of retinoblastoma gene product in neonatal cardiac myocytes. Circ. Res. 80:228-241.
28. Pardee, A.B. 1989. G1 events and regulation of cell proliferation. Science. 246:603-608.
29. Polyak, K., et al. 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 78:59-66.
30. Toyoshima, H., and Hunter, T. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell. 78:67-74.
31. Braun-Dullaeus, R.C., et al. 1997. Loss of p27Kip1 and induction of Cdk1 in the rat carotid artery following balloon catheter injury. In vivo and in vitro influence of rapamycin. FASEB J. 11:A153. (Abstr.)
32. Tanner, F.C., et al. 1998. Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ. Res. 82:396-403.
33. Kiyokawa, H., et al. 1996. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27Kip1. Cell. 85:721-732.
34. Fero, M.L., et al. 1996. A syndrome of multiorgan hyperplasia with features of gigantism, tumorgenesis, and female sterility in p27(Kip1)-deficient mice. Cell. 85:733-744.
35. Polyak, K., et al. 1994. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8:9-22.
36. Reynisdottir, I., Polyak, K., Iavarone, A., and Massague, J. 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev. 9:1831-1845.
37. Kamesaki, H., Nishizawa, K., Michaud, G.Y., Cossman, J., and Kiyono, T. 1998. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells. J. Immunol. 160:770-777.
38. Braun-Dullaeus, R.C., Mann, M.J., von der Leyen, H.E., Sherwood, S.W., and Dzau, V.J. 1997. Evidence for cell cycle-dependent phenotypic modulation of vascular smooth muscle cells. Circulation. 96(Suppl.):I-1586. (Abstr.)
39. Steller, H. 1995. Mechanisms and genes of cellular suicide. Science. 267:1445-1448.
40. White, E. 1996. Life, death, and the pursuit of apoptosis. Genes Dev. 10:1-15.